Klaus-Dieter Wernecke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Klaus-Dieter Wernecke has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Spies
Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Anesthesiology and Intensive Care Medicine (CCM | CVK), Augustenburger Platz 1, 13353 Berlin, Germany
3 shared publications - Christian von Heymann
Department of Anesthesiology and Intensive Care Medicine, University Hospital Charité, Charitéplatz 1, Germany
2 shared publications Andrea Heger
Octapharma GmbH, Langenfeld, Germany
1 shared publicationAnett Reißhauer
1 shared publication- Herko Grubitzsch
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Augustenburger Platz 1, Berlin, 13353, Germany
1 shared publication Kai Hermanns
1 shared publication
Latest Publications
- 30 April 2012
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 46 (2) , 129-136
Clotting factor activity in thawed Octaplas® LG during storage at 2–6°C for 6days from a quality assurance point of view
- 30 April 2012
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 46 (2) , 129-136
Clotting factor activity in thawed Octaplas® LG during storage at 2–6°C for 6days from a quality assurance point of view
- Open Access
- 14 September 2009
- Published by Springer Nature in Critical Care
- Vol. 13 (5) , R149
Perioperative indocyanine green clearance is predictive for prolonged intensive care unit stay after coronary artery bypass grafting - an observational study
Introduction: During cardiac surgery with cardiopulmonary bypass (CPB) haemodilution occurs. Hepatic dysfunction after CPB is a rare, but serious, complication. Clinical data have validated the plasma-disappearance rate of indocyanine green (PDR ICG) as a marker of hepatic function and perfusion. Primary objective of this analysis was to investigate the impact of haemodilutional anaemia on hepatic function and perfusion by the time course of PDR ICG and liver enzymes in elective CABG surgery. Secondary objective was to define predictors of prolonged ICU treatment like decreased PDR ICG after surgery. Methods: 60 Patients were subjected to normothermic CPB with predefined levels of haemodilution anaemia (haemotacrit (Hct) of 25% versus 20% during CPB). Hepatic function and perfusion was assessed by PDR ICG, plasma levels of aspartate aminotransferase (ASAT) and α-GST. Prolonged ICU treatment was defined as treatment ≥ 48 hours. Results: Logistic regression analysis showed that all postoperative measurements of PDR ICG (P < 0.01), and the late postoperative ASAT (P < 0.01) measurement were independent risk factors for prolonged ICU treatment. The predictive capacity for prolonged ICU treatment was best of the PDR ICG one hour after admission to the ICU. Furthermore, the time course of PDR ICG as well as ASAT and α-GST did not differ between groups of haemodilutional anaemia. Conclusions: Our study provides evidence that impaired PDR ICG as a marker of hepatic dysfunction and hypoperfusion may be a valid marker of prolonged ICU treatment. Additionally this study provides evidence that haemodilutional anaemia to a Hct of 20% does not impair hepatic function and perfusion. Trial registration: [ISRCTN35655335]
- 14 September 2009
- Published by Springer Nature in Critical Care
- Vol. 13 (5) , R149
Open AccessPerioperative indocyanine green clearance is predictive for prolonged intensive care unit stay after coronary artery bypass grafting - an observational study
Introduction: During cardiac surgery with cardiopulmonary bypass (CPB) haemodilution occurs. Hepatic dysfunction after CPB is a rare, but serious, complication. Clinical data have validated the plasma-disappearance rate of indocyanine green (PDR ICG) as a marker of hepatic function and perfusion. Primary objective of this analysis was to investigate the impact of haemodilutional anaemia on hepatic function and perfusion by the time course of PDR ICG and liver enzymes in elective CABG surgery. Secondary objective was to define predictors of prolonged ICU treatment like decreased PDR ICG after surgery. Methods: 60 Patients were subjected to normothermic CPB with predefined levels of haemodilution anaemia (haemotacrit (Hct) of 25% versus 20% during CPB). Hepatic function and perfusion was assessed by PDR ICG, plasma levels of aspartate aminotransferase (ASAT) and α-GST. Prolonged ICU treatment was defined as treatment ≥ 48 hours. Results: Logistic regression analysis showed that all postoperative measurements of PDR ICG (P < 0.01), and the late postoperative ASAT (P < 0.01) measurement were independent risk factors for prolonged ICU treatment. The predictive capacity for prolonged ICU treatment was best of the PDR ICG one hour after admission to the ICU. Furthermore, the time course of PDR ICG as well as ASAT and α-GST did not differ between groups of haemodilutional anaemia. Conclusions: Our study provides evidence that impaired PDR ICG as a marker of hepatic dysfunction and hypoperfusion may be a valid marker of prolonged ICU treatment. Additionally this study provides evidence that haemodilutional anaemia to a Hct of 20% does not impair hepatic function and perfusion. Trial registration: [ISRCTN35655335]
- 1 January 2006
- Published by American Psychological Association (APA)
Freiburg Questionnaire--Stages of Chronic Pain Management
- 1 January 2006
- Published by American Psychological Association (APA)
Freiburg Questionnaire--Stages of Chronic Pain Management